Oric Pharmaceuticals, Inc.
- Stock
- Ticker ORIC
- ISIN US68622P1093
- Nasdaq
Performance, volatility and drawdowns of Oric Pharmaceuticals, Inc. since 04/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,027. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −93.9% in 11/2022, measured from the peak in 12/2020. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -40 | -33 | -39 | -37 | -35 | -40 | -45 | -52 |
| EBITDA | -39 | -32 | -39 | -36 | -34 | -39 | -45 | -51 |
| Net income | -36 | -30 | -36 | -33 | -31 | -36 | -41 | -48 |
| Earnings per share | -0.51 | -0.42 | -0.47 | -0.33 | -0.27 | -0.34 | -0.38 | -0.44 |
| Balance sheet | ||||||||
| Total assets | 274 | 243 | 347 | 431 | 409 | 437 | 405 | 367 |
| Liabilities | 31 | 23 | 23 | 24 | 25 | 21 | 23 | 27 |
| Equity | 243 | 220 | 324 | 407 | 384 | 416 | 381 | 340 |
| Cash | 59 | 49 | 76 | 50 | 46 | 56 | 37 | 34 |
| Cash flow | ||||||||
| Operating cash flow | -28 | -33 | -31 | -25 | -22 | -32 | -32 | -42 |
| Capital expenditure | -0.2 | -0.4 | -0.1 | 0.0 | -0.2 | 0.0 | -0.4 | -0.1 |
| Free cash flow | -28 | -33 | -31 | -25 | -23 | -32 | -32 | -42 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2023 at +56.2%, weakest 2022 at −59.9%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 16 Nov 2026 | −$0.44 |
| 3 Aug 2026 | −$0.38 |
| 4 May 2026 | −$0.34 |
| 23 Feb 2026 | −$0.27 |
| 13 Nov 2025 | −$0.33 |
| 12 Aug 2025 | −$0.47 |
| 5 May 2025 | −$0.42 |
| 18 Feb 2025 | −$0.51 |
| 12 Nov 2024 | −$0.49 |
| 12 Aug 2024 | −$0.45 |
| 6 May 2024 | −$0.37 |
| 11 Mar 2024 | −$0.50 |
Key metrics
Metrics of 17 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €693m
- Market cap in trading currency
- $765m
- Enterprise value
- $504m
- P/E
- –
- P/S
- –
- P/B
- 2.25
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -16.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$170m
- Net income
- −$156m
- Earnings per share
- −$1.43
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -41.8%
- Return on assets
- -42.5%
Balance sheet and cash flow
- Cash
- $261m
- Cash per share
- $2.51
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 11.09
- Book value per share
- $3.27
- Operating cash flow
- −$129m
- Free cash flow
- −$129m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 104m
- Volume
- 1.46m
- Avg. volume 3 months
- 1.57m
- Relative volume
- 0.9
Price and technicals
- Price
- $7.36
- 1 day
- −4.4%
- 52-week high
- $14.65
- 52-week low
- $7.36
- Distance to 52-week high
- −49.8%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −33.6%
- Distance to 200-day line
- −32.6%
- RSI (14)
- 32
- Volatility 1M
- 147.3%
Performance
- 1 week
- −6.4%
- 1 month
- −46.0%
- 3 months
- −45.3%
- 6 months
- −11.5%
- YTD
- −10.0%
- 1 year
- −35.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ORIC performed since 04/2020?
$10,000 grew to $2,856 by 20 Nov 2026, which is −17.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ORIC?
Volatility was 82.5% per year, measured on monthly returns. The largest decline from a peak was −93.9%, with the low in 11/2022.
How does ORIC compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.2% per year at 15.0% volatility, ORIC returned −17.4% at 82.5%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.